Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 33, 2003 - Issue 18
149
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A Total Synthesis of the Antibiotic DB-2073

, &
Pages 3173-3181 | Received 18 Dec 2002, Published online: 17 Aug 2006
 

Abstract

A convergent aromatic annulation strategy based on the Michael addition of the dimethyl-1,3-acetonedicarboxylate 1 anion to 2-hexynal 2, followed by a regiocontrolled Dieckmann-type cyclization, has been applied to a total synthesis of the antibiotic, DB-2073 I. This tandem annulation reaction generates the fully substituted aromatic intermediate 3, which was transformed by a five-step sequence to I.

In recent years we have developed a total and a formal synthesis of mycophenolic acid [Covarrubias-Zúñiga, A.; González-Lucas, A. Tetrahedron Lett. 1998, 39, 2881; Covarrubias-Zúñiga, A.; Díaz-Domínguez, J.; Olguín-Uribe, J.S. Synthetic Communications 2001, 31, 1373.] using as key step tandem reactions based on Michael addition and intramolecular Dieckmann-cyclization; In this article we utilize this synthetic approach for the total synthesis of the resorcinol DB-2073 I. This tetrasubstituted resorcinol was isolated and purified from pseudomonas B-9004, showing antibacterial and antifungal activities [Kanda, N.; Ishizaki, N.I.; Oshima, M.; Handa, A.; Kitahara, T.J. Antibiotics 1975, 28, 935.]. The molecular formula of DB-2073 was established by spectroscopic methods [Kitahara, T.; Kanda, N. J. Antibiotics 1975, 28, 943.], as 2-hexyl-5-propyl-resorcinol I.

Acknowledgments

This research was supported by a Grant-in-Aid for Scientific Research No. 27610-E from CONACYT, México. The authors thank Dr. N. Zúñiga for helpful discussions, We thank Messrs. R. Gaviño, R. Patiño, L. Velasco, and F. J. Pérez for running the spectra.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.